Evidence map›Paper›PMID 41703101›Full record

ReviewMolecular neurobiology2026

Mapping the Evolution of Experimental Autoimmune Encephalomyelitis Research (2000-2024): A Global Bibliometric and Knowledge Domain Analysis.

Zhihua Dong, Yu He, Taisong Yin, Kun Xu, Xueli Liu, Hongxia Han, Lijuan Song, Zhibin Ding, Xinyi Li, Yanbing Su

Abstract readReview
In one paragraph

Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhihua Dong *Department of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, No. 99, Longcheng Avenue, Longcheng Subdistrict, Xiaodian District, Taiyuan City, Shanxi Province, China.
Yu He *Department of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, No. 99, Longcheng Avenue, Longcheng Subdistrict, Xiaodian District, Taiyuan City, Shanxi Province, China.
Taisong YinDepartment of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, No. 99, Longcheng Avenue, Longcheng Subdistrict, Xiaodian District, Taiyuan City, Shanxi Province, China.
Kun XuThe Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple, Sclerosis of State Administration of Traditional Chinese Medicine/Research Center of Neurobiology, Shanxi University of Chinese Medicine, Jinzhong, China.
Xueli LiuSchool of Management, Shanxi Medical University, Taiyuan, China.
Hongxia HanShanxi Cardiovascular Hospital, Cardiovascular Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Lijuan SongThe Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple, Sclerosis of State Administration of Traditional Chinese Medicine/Research Center of Neurobiology, Shanxi University of Chinese Medicine, Jinzhong, China.
Zhibin DingDepartment of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, No. 99, Longcheng Avenue, Longcheng Subdistrict, Xiaodian District, Taiyuan City, Shanxi Province, China. zhibinding2013@163.com.
Xinyi LiDepartment of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, No. 99, Longcheng Avenue, Longcheng Subdistrict, Xiaodian District, Taiyuan City, Shanxi Province, China. xinyili2003@aliyun.com.
Yanbing SuOffice of Research, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, No. 99, Longcheng Avenue, Longcheng Subdistrict, Xiaodian District, Taiyuan City, Shanxi Province, China. suyanbing@sxbqeh.com.cn.

Funding

National Natural Science Foundation of China No. 82301579Shanxi Medical University Third Hospital Talent Introduction Research Fund Project No. 2021RC033Shanxi University of Chinese Medicine Science and Technology Innovation Capability Cultivation Plan National Natural Science Foundation Cultivation Special Project No. 2024PY-NS-012Special Project for Science and Technology Cooperation and Exchange in Shanxi Province No. 202304041101004
6 · The paper itself

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a pivotal animal model for multiple sclerosis (MS) research. This study provides a comprehensive bibliometric analysis of 9,435 EAE-related publications from the Web of Science Core Collection (2000-2024) to map the research landscape, identify trends, and highlight emerging frontiers. The analysis reveals a shift from initial rapid growth to a stabilized output, with the USA, Germany, and China as the leading contributors. Immunology and Neurosciences form the core disciplines, with increasing integration of cell biology, microbiology, and pharmacology. Co-citation and keyword analyses demonstrate a clear evolution in research focus: while early studies centered on T-cell biology and classic neuroinflammation, recent investigations emphasize the gut-brain-immune axis, microglial/astrocyte reactivity, immunometabolism, and novel therapeutic strategies like microbiota-targeted interventions and nanomedicine. The Th17/Treg axis remains a central immunoregulatory hub. This analysis delineates the intellectual structure of the field, underscoring its progression from foundational immune mechanisms to complex, system-level understandings of neuroimmune crosstalk, and identifies promising directions for future MS therapeutic development.Experimental autoimmune encephalomyelitis (EAE) is a pivotal animal model for multiple sclerosis (MS) research. This study provides a comprehensive bibliometric analysis of 9,435 EAE-related publications from the Web of Science Core Collection (2000-2024) to map the research landscape, identify trends, and highlight emerging frontiers. The analysis reveals a shift from initial rapid growth to a stabilized output, with the USA, Germany, and China as the leading contributors. Immunology and Neurosciences form the core disciplines, with increasing integration of cell biology, microbiology, and pharmacology. Co-citation and keyword analyses demonstrate a clear evolution in research focus: while early studies centered on T-cell biology and classic neuroinflammation, recent investigations emphasize the gut-brain-immune axis, microglial/astrocyte reactivity, immunometabolism, and novel therapeutic strategies like microbiota-targeted interventions and nanomedicine. The Th17/Treg axis remains a central immunoregulatory hub. This analysis delineates the intellectual structure of the field, underscoring its progression from foundational immune mechanisms to complex, system-level understandings of neuroimmune crosstalk, and identifies promising directions for future MS therapeutic development.

Indexed as

BibliometricsEncephalomyelitis, Autoimmune, ExperimentalAnimalsHumansMultiple SclerosisBibliometricsExperimental Autoimmune EncephalomyelitisKnowledge mappingNeuroimmunology

Identifiers

PMID41703101
PMCPMC12913296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.